Circulating Tumor DNA Testing in Curatively Resected CRC and Salvage Resection
This cohort study examines the potential curative clinical outcomes of adding serial circulating tumor DNA assays to standard-of-care imaging surveillance in patients with resected colorectal cancer (CRC).